Fractional dose yellow fever vaccination, coming of age

Affiliations

¹ Department of Infectious Diseases, Leiden University Medical Center, Leiden 2333 ZA, Netherlands.
² Department of Infectious Diseases, Leiden University Medical Center, Leiden 2333 ZA, Netherlands. Electronic address: l.g.visser@lumc.nl.

Comment

Anna H E Roukens et al. Lancet Infect Dis. 2023 Aug.

. 2023 Aug;23(8):889-890.

doi: 10.1016/S1473-3099(23)00205-0. Epub 2023 Apr 28.

¹ Department of Infectious Diseases, Leiden University Medical Center, Leiden 2333 ZA, Netherlands.
² Department of Infectious Diseases, Leiden University Medical Center, Leiden 2333 ZA, Netherlands. Electronic address: l.g.visser@lumc.nl.

No abstract available

Conflict of interest statement

We declare no competing interests.

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Kimathi D, Juan-Giner A, Orindi B, Grantz KH, Bob NS, Cheruiyot S, Hamaluba M, Kamau N, Fall G, Dia M, Mosobo M, Moki F, Kiogora K, Chirro O, Thiong'o A, Mwendwa J, Guantai A, Karanja HK, Gitonga J, Mugo D, Ramko K, Faye O, Sanders EJ, Grais RF, Bejon P, Warimwe GM. Kimathi D, et al. Lancet Infect Dis. 2023 Aug;23(8):974-982. doi: 10.1016/S1473-3099(23)00114-7. Epub 2023 Apr 28. Lancet Infect Dis. 2023. PMID: 37127045 Free PMC article. Clinical Trial.
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Juan-Giner A, Namulwana ML, Kimathi D, Grantz KH, Fall G, Dia M, Bob NS, Sall AA, Nerima C, Sahani MK, Mulogo EM, Ampeire I, Hombach J, Nanjebe D, Mwanga-Amumpaire J, Cummings DAT, Bejon P, Warimwe GM, Grais RF. Juan-Giner A, et al. Lancet Infect Dis. 2023 Aug;23(8):965-973. doi: 10.1016/S1473-3099(23)00131-7. Epub 2023 Apr 28. Lancet Infect Dis. 2023. PMID: 37127047 Clinical Trial.